Clinical Trials and Research
Login or register to access the content restricted to healthcare professionals only
ADVANCED CLINICAL
|
Clinical Trial | Extract | Background | Current status | Comment |
Phase I PK Study | Bod ECS315 | Pharmacokinetics safety and tolerability of CBD extract |
INITIATED IN PROGRESS COMPLETED |
Differentiated by our R&D. This work optimised the design of our schedule 3 clinical trial |
Toxicology | Bod ECS315 | Safety evaluation of ECS315 For Novel Food registration |
INITIATED IN PROGRESS COMPLETED |
We are 1 of only 6company globally to have secured a validated Novel Food Application. This is mandatory for CBD to sold in the UK and EU |
BODOLOS Observational Study | Bod ECS315 & Bod ECS100 | Real world evidence on doctors CBD prescribing habits |
INITIATED IN PROGRESS COMPLETED |
Provided important insight into dosing decisions and design of our schedules 3 clinical trial |
CBG Pilot Study | Bod ECS317 | Evaluation of the efficiency of a novel CBG compound |
INITIATED IN PROGRESS COMPLETED |
Investigate the effect of CBG on symptoms associated with fibromyalgia, inflammatory bowel disease and anxiety |
Project Chang’e | Bod ECS317 & Bod ECS100 | Evaluating the combination of different cannabinoids and probiotics targeting stress, anxiety and inflammation in animals |
INITIATED IN PROGRESS |
Data will support future product launches using combination of CBG and CBD |
Phase1 PK study | BOD Bio Absorb | Pharmacokinetics, safety and tolerability of novel CBD compound |
INITIATED IN PROGRESS COMPLETED |
Data will support FDA registration and others commercial opportunities |
Phase II Insomnia Study | Bod Bio Absorb | Using a novel CBD to treat insomnia |
INITIATED IN PROGRESS |
clinical trial will allow Bod to secure a registration from TGA. this will allow the product to be sold in Australian Pharmacy’s over the counter. |
Long-COVID Study | Bod ECS315 | Evaluating the efficacy of CBD for symptoms associated with long-COVID |
INITIATED IN PROGRESS |
This study provide a unique opportunity to alleviate multiple symptoms of long covid using one medicine |
Emerald Study Phase II study | Bod ECS315 | The use of CBD in slowing progression of Motor Neuron Disease |
INITIATED IN PROGRESS |
Collaboration with Gold Coast University Hospital |
Phase I CBN Insomnia Study | Bod Es310 | Using CBN treating primary insomnia |
INITIATED IN PROGRESS |
Collaboration with Sydney University & The Woolcock Institute |
Project Skin | Novel Protein | Evaluating the efficacy of a novel protein for inhibiting free radical damage on skin |
INITIATED IN PROGRESS |
At completion, Bod will own unique and novel delivery format of an anti-aging agent for topical use |